RB has been the subject of several other reports. Deutsche Bank reaffirmed a buy rating on shares of Reckitt Benckiser Group in a report on Tuesday. Royal Bank of Canada set a GBX 5,100 ($66.64) price target on Reckitt Benckiser Group and gave the stock a sell rating in a report on Monday. UBS Group reaffirmed a neutral rating and set a GBX 6,400 ($83.63) price target on shares of Reckitt Benckiser Group in a report on Monday. JPMorgan Chase & Co. set a GBX 9,000 ($117.60) price target on Reckitt Benckiser Group and gave the stock a buy rating in a report on Monday. Finally, Jefferies Financial Group set a GBX 5,000 ($65.33) price target on Reckitt Benckiser Group and gave the stock a sell rating in a report on Monday. Three analysts have rated the stock with a sell rating, six have given a hold rating and ten have given a buy rating to the stock. The company currently has an average rating of Hold and an average target price of GBX 6,974.38 ($91.13).
RB stock opened at GBX 5,969 ($78.00) on Tuesday. Reckitt Benckiser Group has a twelve month low of GBX 5,562 ($72.68) and a twelve month high of GBX 8,110.43 ($105.98).
The firm also recently disclosed a dividend, which will be paid on Thursday, May 23rd. Shareholders of record on Thursday, April 18th will be given a GBX 100.20 ($1.31) dividend. This is a boost from Reckitt Benckiser Group’s previous dividend of $70.50. The ex-dividend date is Thursday, April 18th. This represents a yield of 1.67%.
In other Reckitt Benckiser Group news, insider Elane Stock acquired 1,860 shares of the business’s stock in a transaction on Tuesday, February 19th. The stock was purchased at an average price of GBX 6,233 ($81.45) per share, for a total transaction of £115,933.80 ($151,488.04).
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers products for the treatment of analgesic and gastro-intestinal problems, sore throat, cough, pain, and flu, as well as wellness products in sexual wellbeing, footcare, vitamins, and supplements under the Durex, Gaviscon, Nurofen, Mucinex, Scholl/Amopé, and Strepsils brand names.
Read More: How liquidity affects the bid-ask spread
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.